TP53 and breast cancer: Breast cancer (MCF-7) and human colorectal carcinoma cells (HCT116) treated with 1 μM melatonin exhibited p53 activation and accumulation which inhibited proliferation and protected against DNA damage through the ATP-dependent phosphorylation of p53 at serine 15 (Ser15) [848].